Genevieve Steiner-Lim

Geriatric Medicine and Medical Cannabis

A Talk by Associate Professor Genevieve Steiner-Lim (NHMRC Emerging Leadership Fellow II and Clinical Research Platform Lead, NICM Health Research Institute, Western Sydney University)

About this Talk

Dementia is the greatest cause of disability in Australians aged 65 years and over, and currently, there is no cure. With a 98% failure rate at developing Alzheimer’s disease drugs since 2004, new therapeutic candidates are urgently needed. Cannabis sativa L. contains over 100 phytocannabinoids and other compounds, some of which may have the therapeutic potential to address multiple aspects of dementia pathophysiology and aid with clinical management. This presentation will outline the current preclinical and clinical evidence on medicinal cannabis for dementia and the approach our team is taking for a new clinical trial using a CBD-rich cannabis formulation to tackle early-stage Alzheimer’s disease.

27 October 2023, 02:50 AM

02:50 AM - 03:50 AM

About The Speakers

Genevieve Steiner-Lim

Associate Professor Genevieve Steiner-Lim

NHMRC Emerging Leadership Fellow II and Clinical Research Platform Lead, NICM Health Research Institute, Western Sydney University

Associate Professor Genevieve Steiner-Lim is an NHMRC Emerging Leadership Fellow II and the Clinical Research Platform Lead at NICM Health Research Institute, Western Sydney University.

PlantMed

Diamond

Cannatrek

Platinum

Kind Medical

Platinum

MedCan Australia

Platinum

Alfie Therapeutics

Gold

Cymra Life Sciences

Gold

Endoca Australia

Gold

Entoura Australia

Gold

Grandiosa

Gold

GrindeROO

Gold

Little Green Pharma

Gold

Mi Dispensary

Gold

Palneted

Gold

Sativite

Gold

Spectrum Therapeutics

Gold

Tasmanian Botanics

Gold

The Entourage Effect

Gold

Vapormed

Gold

Want to sponsor this event? Contact Us